Resilience Biotechnologies receives significant funding to produce made-in-Canada vaccines, Ottawa extends the CAN Health Network project in Ontario by one year with a $3.25-million investment, Canada’s nuclear leaders collaborate on the decommissioning process, and more.
Topic: future pandemics
The Short Report – April 21, 2021: SIF gets $7.2 billion in 2021 federal budget, BC budget invests in new strategic fund, Biden’s funding surge, a boost for the Stem Cell Network, and more
The 2021 federal budget gives a big boost to the NRC’s Industrial Research Assistance Program, BC budget provides $500 million to new fund for tech startups, US President Joe Biden proposes funding surge for federal research agencies, Canada’s Stem Cell Network to receive $45 million dollars for regenerative medicine therapies, and more.
The Short Report – March 3, 2021: A report on inclusive innovation, an urban health research network, a potential DARPA for Canada, and more
The Brookfield Institute and the Munk School of Global Affairs produce an online tool to monitor data and analysis of Canada’s inclusive innovation system; U of T and Denmark’s Novo Nordisk A/S invest $40 million on supporting healthier urban populations and finding solutions for chronic illnesses, and more.
Feds invest $887 million to ensure reliable vaccine supply for COVID-19, other pandemics
The federal government’s investment of $887 million make Canada self-sufficient in manufacturing vaccines against COVID-19 and future pandemics, say medical and other experts. Along with Canadian-led vaccine development, Ottawa is investing in a network of small-scale vaccine manufacturing facilities that together will be able to produce enough vaccine for Canada’s population during pandemics.